Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 322,357 | 294,666 | 240,175 | 255,165 | 251,519 |
| Cost of Goods | 190,434 | 187,681 | 149,666 | 150,969 | 174,172 |
| Gross Profit | 131,923 | 106,985 | 90,509 | 104,196 | 77,347 |
| Operating Expenses | 132,396 | 116,289 | 92,444 | 89,789 | 84,417 |
| Operating Income | -39 | -8,623 | -1,269 | 15,376 | -6,898 |
| Interest Expense | 119 | 243 | 826 | 1,024 | 987 |
| Other Income | 60,386 | -1,060 | 3,344 | 278 | -2,479 |
| Pre-tax Income | 60,228 | -9,926 | 1,249 | 14,630 | -10,364 |
| Income Tax | 13,723 | -3,266 | -2,398 | 4,810 | -7,577 |
| Net Income Continuous | 46,505 | -6,660 | 3,647 | 9,820 | -2,787 |
| Minority Interests | -2,434 | -922 | N/A | N/A | N/A |
| Net Income | $48,939 | $-5,738 | $3,647 | $9,820 | $-2,787 |
| EPS Basic Total Ops | 1.04 | -0.12 | 0.08 | 0.22 | -0.06 |
| EPS Basic Continuous Ops | 0.99 | -0.14 | 0.08 | 0.22 | -0.06 |
| EPS Diluted Total Ops | 0.98 | -0.12 | 0.08 | 0.21 | -0.06 |
| EPS Diluted Continuous Ops | 0.93 | -0.14 | 0.08 | 0.21 | -0.06 |
| EPS Diluted Before Non-Recurring Items | 0.36 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $18,071 | $7,893 | $14,541 | $30,054 | $6,354 |